---
title: "Touyun Biotech Forecasts Swing to 2025 Profit"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/280463973.md"
description: "Touyun Biotech Forecasts Swing to 2025 Profit"
datetime: "2026-03-25T11:31:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280463973.md)
  - [en](https://longbridge.com/en/news/280463973.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280463973.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/280463973.md) | [English](https://longbridge.com/en/news/280463973.md)


# Touyun Biotech Forecasts Swing to 2025 Profit

Touyun Biotech Forecasts Swing to 2025 Profit

### 相關股票

- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [TOUYUN BIOTECH (01332.HK)](https://longbridge.com/zh-HK/quote/01332.HK.md)

## 相關資訊與研究

- [Novo Nordisk Wins FDA Nod for First Once‑Weekly Basal Insulin Awiqli in U.S.](https://longbridge.com/zh-HK/news/280789111.md)
- [BUZZ-Caribou rises on FDA's regenerative medicine advanced therapy tag for blood cancer therapy](https://longbridge.com/zh-HK/news/281186075.md)
- [Telomir submits IND for Telomir-1 to treat advanced and metastatic TNBC](https://longbridge.com/zh-HK/news/281174396.md)
- [Insmed Sees Rising Physician Adoption of Brinsupri, Morgan Stanley Says](https://longbridge.com/zh-HK/news/281049788.md)
- [Iterum Therapeutics Received Notice of Delisting](https://longbridge.com/zh-HK/news/281174211.md)